Renaissance Technologies’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-52
| Closed | -$206K | – | 4493 |
|
2022
Q3 | $206K | Sell |
52
-249
| -83% | -$986K | ﹤0.01% | 3372 |
|
2022
Q2 | $785K | Sell |
301
-146
| -33% | -$381K | ﹤0.01% | 2868 |
|
2022
Q1 | $1.44M | Buy |
+447
| New | +$1.44M | ﹤0.01% | 2471 |
|
2021
Q4 | – | Sell |
-41
| Closed | -$381K | – | 4295 |
|
2021
Q3 | $381K | Sell |
41
-74
| -64% | -$688K | ﹤0.01% | 2999 |
|
2021
Q2 | $1.17M | Buy |
+115
| New | +$1.17M | ﹤0.01% | 2594 |
|
2021
Q1 | – | Sell |
-183
| Closed | -$1.11M | – | 3797 |
|
2020
Q4 | $1.11M | Buy |
183
+29
| +19% | +$176K | ﹤0.01% | 2446 |
|
2020
Q3 | $554K | Sell |
154
-101
| -40% | -$363K | ﹤0.01% | 2777 |
|
2020
Q2 | $989K | Sell |
255
-26
| -9% | -$101K | ﹤0.01% | 2544 |
|
2020
Q1 | $529K | Sell |
281
-10
| -3% | -$18.8K | ﹤0.01% | 2738 |
|
2019
Q4 | $1.5M | Buy |
291
+28
| +11% | +$144K | ﹤0.01% | 2451 |
|
2019
Q3 | $927K | Buy |
263
+21
| +9% | +$74K | ﹤0.01% | 2633 |
|
2019
Q2 | $2.04M | Buy |
242
+118
| +95% | +$993K | ﹤0.01% | 2319 |
|
2019
Q1 | $1.6M | Buy |
124
+122
| +6,100% | +$1.58M | ﹤0.01% | 2434 |
|
2018
Q4 | $36K | Buy |
+2
| New | +$36K | ﹤0.01% | 3305 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 3320 |
|
2018
Q2 | – | Sell |
-2
| Closed | -$71K | – | 3591 |
|
2018
Q1 | $71K | Buy |
+2
| New | +$71K | ﹤0.01% | 3285 |
|
2015
Q1 | – | Hold |
0
| – | -$54K | – | 3386 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 2865 |
|